ZNF790 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.23010001973745E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.27839999697343E-08 |
Normal-vs-Stage2 |
4.26230000000194E-05 |
Normal-vs-Stage3 |
3.63999999997144E-06 |
Normal-vs-Stage4 |
1.95416999999587E-05 |
Stage1-vs-Stage2 |
9.903600E-01 |
Stage1-vs-Stage3 |
7.600800E-01 |
Stage1-vs-Stage4 |
3.360000E-01 |
Stage2-vs-Stage3 |
8.444800E-01 |
Stage2-vs-Stage4 |
4.478200E-01 |
Stage3-vs-Stage4 |
5.305200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.96109997527583E-09 |
Normal-vs-AfricanAmerican |
5.54470000024843E-07 |
Normal-vs-Asian |
8.997500E-03 |
Caucasian-vs-AfricanAmerican |
8.334800E-01 |
Caucasian-vs-Asian |
8.334800E-01 |
AfricanAmerican-vs-Asian |
8.971600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.42900000113622E-09 |
Normal-vs-Female |
1.041500E-04 |
Male-vs-Female |
2.350000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.84489999999604E-05 |
Normal-vs-Extreme_Weight |
2.55460097520199E-11 |
Normal-vs-Obese |
2.24609999999181E-06 |
Normal-vs-Extreme_Obese |
6.416100E-04 |
Normal_Weight-vs-Extreme_Weight |
1.173810E-01 |
Normal_Weight-vs-Obese |
8.218000E-01 |
Normal_Weight-vs-Extreme_Obese |
7.125000E-01 |
Extreme_Weight-vs-Obese |
1.835780E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.528600E-01 |
Obese-vs-Extreme_Obese |
5.638200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.12139999952632E-07 |
Normal-vs-Age(41-60Yrs) |
5.78530000017174E-07 |
Normal-vs-Age(61-80Yrs) |
3.22969995192324E-09 |
Normal-vs-Age(81-100Yrs) |
5.21669999975494E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.761600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.721800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.732800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.473590E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.044400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.477800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.53720000009672E-07 |
Normal-VS-Type2 PRCC |
2.01749950079488E-10 |
Normal-VS-KIRP CIMP |
1.22819999948121E-07 |
Normal-VS-Unclassified PRCC |
1.994010E-04 |
Type1 PRCC-VS-Type2 PRCC |
3.838600E-03 |
Type1 PRCC-VS-KIRP CIMP |
2.429500E-02 |
Type1 PRCC-VS-Unclassified PRCC |
7.740400E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.497600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.451800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.192400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.26470000717217E-09 |
Normal-vs-N1 |
1.57725999999636E-05 |
Normal-vs-N2 |
3.73090000005405E-07 |
N0-vs-N1 |
6.242800E-01 |
N0-vs-N2 |
2.864100E-02 |
N1-vs-N2 |
2.561700E-02 |
|
|